Jiahui Opens Shanghai Cell Therapy Center for Global CAR-T Patients
SHANGHAI – October 29, 2026 -- Jiahui International Hospital has launched the Jiahui International Cell Therapy Center to treat CAR-T patients from China and abroad, citing rising international demand. The hospital handles nearly 500,000 patient visits a year from 180 countries and regions.
Center unveiled at inaugural summit with viewers from 14 countries
The center was introduced on October 23 at the first Jiahui International Cell Therapy Summit. Jiahui International Hospital hosted the event, and Jiahui Medical Research & Education Group (J-Med) co-organized it. Livestream viewing registrations came from 14 countries and regions.
Prof. HAO Siguo, Chief of Hematology at Jiahui International Cancer Center (JICC), and Prof. XUAN Linli, Chief of Medical Oncology at JICC, joined experts discussing cellular therapies for blood cancers, solid tumors and autoimmune diseases.